-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[April 19, 2021/Medical Information List] Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan ; Puli Pharmaceuticals 500mg levofloxacin tablets obtained drug registration approval; Incorporated 700 million put into construction an annual output of 500,000 Tons of carboxyl-butadiene nitrile latex, 100,000 tons of DOTP project; Wantai Biotech's new crown antigen detection kit was approved to be sold in the German market.
[April 19, 2021/list of medical information] ; Prily Pharmaceuticals 500mg levofloxacin tablets obtained drug registration approval; Ingram Medical 700 million invested in the construction of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP projects; Wantai Biotechnology The new crown antigen detection kit has been approved for sale in the German market.
Part 1 Policy Brief Part 1 Policy Brief
Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan
Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuanOn the 19th, according to Jiangxi’s announcement, the domestic bivalent cervical cancer vaccine was launched in Jiangxi.
180 pharmaceutical companies participate in a new round of centralized procurement in Fujian
180 pharmaceutical companies participate in a new round of centralized procurement in FujianRecently, the Fujian Medical Insurance Bureau issued the "Notice on Publicizing the Information of Fujian Province's Drug Centralized Purchase Products in 2021", stating that the application for bulk purchase of drugs in Fujian Province has been completed, and the list of companies and products that meet the application rules will now be announced , The publicity period is until April 22.
Part 2 Observation of Sankei
Part 2 Sankei Observation Part 2 Sankei ObservationIngram Medical 700 million invested in the construction of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP project
Ingram Medical 700 million invested in the construction of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP projectOn the 19th, Intech Medical issued an announcement stating that the company's wholly-owned subsidiary, Anhui Intech, has invested 7 million yuan in the construction of an annual output of 500,000 tons of carboxylated nitrile latex and 100,000 tons of DOTP through the establishment of a holding subsidiary Anhui Kaize.
Biolight intends to spend 11.
Biolight intends to spend 11.
Part 3 Drug News
Part 3 Drug News Part 3 Drug News InformationNew antacid drugs! Shengnuo Medicine's Class 1 new drug initiates Phase 3 clinical trial of reflux esophagitis
New antacid drugs! Shengnuo Medicine's Class 1 new drug initiates Phase 3 clinical trial of reflux esophagitisThe latest news on the Chinese drug clinical trial registration and information disclosure platform, Shengnuo Pharmaceutical's new class 1 chemical drug X842 capsule has started a phase 3 clinical trial for the treatment of reflux esophagitis.
FDA approves innovative oral contraceptive therapy containing new estrogen
FDA approves innovative oral contraceptive therapy containing new estrogenA few days ago, Mayne Pharma announced that the US FDA has approved the company's Nextstellis (drospirenone and estrol compound tablets) to be marketed for the prevention of pregnancy.
Shanghai Pharmaceutical Enalapril Maleate Tablets Passed the Consistency Evaluation
Shanghai Pharmaceutical Enalapril Maleate Tablets Passed the Consistency EvaluationOn the 19th, Shanghai Pharmaceutical issued an announcement stating that Xinya Minhang, a holding subsidiary, had received the "Drug Supplementary Application Approval Notice" (notice number) issued by the State Food and Drug Administration regarding enalapril maleate tablets (5mg, 10mg) : 2021B00893, 2021B00894), the drug passed the quality and efficacy consistency evaluation of generic drugs.
Puli Pharmaceutical 500mg Levofloxacin Tablets Obtained Drug Registration Approval
Puli Pharmaceutical 500mg Levofloxacin Tablets Obtained Drug Registration ApprovalPuli Pharmaceuticals issued an announcement stating that Zhejiang Puli Pharmaceutical Co.
Poinsettia subsidiary obtains the registration certificate of pantoprazole sodium for injection
Poinsettia subsidiary obtains the registration certificate of pantoprazole sodium for injectionPoinsettia issued an announcement stating that its wholly-owned subsidiary Guangzhou Poinsettia Pharmaceutical Co.
Hisun Pharmaceutical Tofacitib Citrate Tablets Obtained Drug Registration Certificate
Hisun Pharmaceutical Tofacitib Citrate Tablets Obtained Drug Registration CertificateHisun Pharmaceutical issued an announcement stating that the company had recently received tofacitib citrate tablets to obtain a drug registration certificate.
Wantai Biotech's new crown antigen detection kit is approved for sale in the German market
Wantai Biotech's new crown antigen detection kit is approved for sale in the German marketWantai Biological released an announcement stating that the company's new coronavirus antigen detection kit (colloidal gold method), with the German name WANTAISARS-CoV-2AgSchnelltest (KolloidalesGold), was recently approved by the German BfArM.
Pfizer and Moderna refuse to cooperate with Johnson & Johnson on coagulation of the new crown vaccine
Pfizer and Moderna refuse to cooperate with Johnson & Johnson on coagulation of the new crown vaccineAccording to a recent report by the Wall Street Journal, Johnson & Johnson contacted Pfizer, Moderna and AstraZeneca to ask them to investigate the coagulation problem caused by the COVID-19 vaccine and "express opinions on safety issues.
Doctors from the Third Hospital of Beijing Medical University Reveal the Shady of Tumor Treatment
Doctors from the Third Hospital of Beijing Medical University Reveal the Shady of Tumor TreatmentOn the 18th, a Zhihu user "Dr.